Suppr超能文献

Fluvoxamine for outpatients with COVID-19: where do we stand?

作者信息

Berwanger Otavio

机构信息

Academic Research Organization (ARO), Hospital Israelita Albert Einstein, Sao Paulo-SP, Brazil.

出版信息

Lancet Glob Health. 2022 Jan;10(1):e2-e3. doi: 10.1016/S2214-109X(21)00501-5. Epub 2021 Oct 28.

Abstract
摘要

相似文献

1
Fluvoxamine for outpatients with COVID-19: where do we stand?
Lancet Glob Health. 2022 Jan;10(1):e2-e3. doi: 10.1016/S2214-109X(21)00501-5. Epub 2021 Oct 28.
3
Fluvoxamine for COVID-19?
Med Lett Drugs Ther. 2021 May 3;63(1623):69-70.
4
Fluvoxamine for COVID-19 outpatients: For the time being, we might prefer to curb our optimism.
Br J Clin Pharmacol. 2022 Oct;88(10):4654-4656. doi: 10.1111/bcp.15451. Epub 2022 Jul 13.
5
Fluvoxamine for Outpatient Management of COVID-19 to Prevent Hospitalization: A Systematic Review and Meta-analysis.
JAMA Netw Open. 2022 Apr 1;5(4):e226269. doi: 10.1001/jamanetworkopen.2022.6269.
7
Fluvoxamine for the treatment of COVID-19.
Lancet Glob Health. 2022 Mar;10(3):e332. doi: 10.1016/S2214-109X(22)00006-7.
8
Fluvoxamine for the treatment of COVID-19.
Lancet Glob Health. 2022 Mar;10(3):e331. doi: 10.1016/S2214-109X(21)00592-1.
9
Fluvoxamine for the treatment of COVID-19.
Lancet Glob Health. 2022 Mar;10(3):e330. doi: 10.1016/S2214-109X(22)00003-1.
10
Fluvoxamine and COVID-19.
WMJ. 2022;121:P2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验